Icon (Close Menu)

Logout

Bart Barlogie Leaves UAMS for New York City

1 min read

If you were wondering where Dr. Bart Barlogie, who is considered one of the top doctors in the world when it comes to treating myeloma, ended up after leaving the University of Arkansas for Medical Sciences, wonder no more.

Barlogie is working at The Mount Sinai Hospital in New York and is beginning to see patients there.

Barlogie, if you recall, founded in 1989 the Myeloma Institute at UAMS in Little Rock.

The institute has treated more than 11,000 patients from all 50 states and more than 50 countries. Myeloma is a rare form of bone marrow cancer.

And it was just in March that the Celgene Corp. of Summit, New Jersey, announced it was giving $10 million to the Myeloma Institute.

UAMS said it would use the grant to create the Bart Barlogie Center for Molecular Diagnostics and the Celgene Distinguished Endowed Chair in Molecular Therapeutics.

Barlogie stepped down as director of the institute in 2014 and helped recruit his successor, Dr. Gareth Morgan, a cancer researcher from London.

Barlogie announced in February that he was leaving UAMS at the end of August. UAMS Chancellor Dan Rahn hosted a campus going away gathering for Barlogie late last month.

A UAMS spokeswoman said in an email to Whispers that she didn’t know Barlogie’s future plans.

“We wish him well,” she said.

Barlogie’s office in New York didn’t immediately return a call for comment.

Send this to a friend